Business Description
General Biologicals Corp
NAICS : 325412
SIC : 2833
ISIN : TW0004117007
Description
General Biologicals Corp is a developer and manufacturer of vitro diagnostic devices in Taiwan. It offers research development, marketing and servicing of products and solutions for hospitals, medical laboratories, blood banks, and research and industry. Its products include Anti-HDV, HIV Ag-Ab COMB, Anti-HBs, and many others.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.13 | |||||
| Debt-to-Equity | 4.79 | |||||
| Debt-to-EBITDA | -12.79 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.2 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.1 | |||||
| 3-Year Book Growth Rate | -10.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.2 | |||||
| 9-Day RSI | 44.23 | |||||
| 14-Day RSI | 42.46 | |||||
| 6-1 Month Momentum % | -11.04 | |||||
| 12-1 Month Momentum % | -14.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.02 | |||||
| Quick Ratio | 0.76 | |||||
| Cash Ratio | 0.53 | |||||
| Days Inventory | 181.64 | |||||
| Days Sales Outstanding | 68.2 | |||||
| Days Payable | 79.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -66.1 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.17 | |||||
| Operating Margin % | -73.41 | |||||
| Net Margin % | -86.35 | |||||
| FCF Margin % | -552.19 | |||||
| ROE % | -42.1 | |||||
| ROA % | -8.32 | |||||
| ROIC % | -8.11 | |||||
| 3-Year ROIIC % | -13.14 | |||||
| ROC (Joel Greenblatt) % | -9.54 | |||||
| ROCE % | -9.83 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 18.42 | |||||
| PS Ratio | 4.75 | |||||
| PB Ratio | 2.88 | |||||
| Price-to-Tangible-Book | 3.34 | |||||
| Price-to-Operating-Cash-Flow | 24.02 | |||||
| EV-to-EBIT | -15.11 | |||||
| EV-to-EBITDA | -19.03 | |||||
| EV-to-Revenue | 11.78 | |||||
| EV-to-FCF | -2.14 | |||||
| Price-to-Median-PS-Value | 1.18 | |||||
| Earnings Yield (Greenblatt) % | -6.62 | |||||
| FCF Yield % | -115.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
General Biologicals Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 242.402 | ||
| EPS (TTM) (NT$) | -3.49 | ||
| Beta | 0.43 | ||
| Volatility % | 25.52 | ||
| 14-Day RSI | 42.46 | ||
| 14-Day ATR (NT$) | 0.457967 | ||
| 20-Day SMA (NT$) | 19.535 | ||
| 12-1 Month Momentum % | -14.5 | ||
| 52-Week Range (NT$) | 18.8 - 30.2 | ||
| Shares Outstanding (Mil) | 59.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
General Biologicals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
General Biologicals Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
General Biologicals Corp Frequently Asked Questions
What is General Biologicals Corp(ROCO:4117)'s stock price today?
The current price of ROCO:4117 is NT$19.30. The 52 week high of ROCO:4117 is NT$30.20 and 52 week low is NT$18.80.
When is next earnings date of General Biologicals Corp(ROCO:4117)?
The next earnings date of General Biologicals Corp(ROCO:4117) is .
Does General Biologicals Corp(ROCO:4117) pay dividends? If so, how much?
General Biologicals Corp(ROCO:4117) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers